MaltSci 麦伴科研

Appearance

Popular Reports / Emerging Frontiers

This report is written by MaltSci based on the latest literature and research findings

What are the applications of 3D bioprinting? ​

Abstract ​

Three-dimensional (3D) bioprinting has emerged as a transformative technology at the intersection of engineering and life sciences, revolutionizing biomedicine by enabling the precise fabrication of complex biological structures. This innovative approach combines living cells with biocompatible materials to create tissue-like constructs that closely mimic the architecture and functionality of human organs. The rapid advancement of 3D bioprinting technologies has garnered significant attention due to their potential applications in various domains, including tissue engineering, regenerative medicine, drug testing, and personalized medicine. As the global demand for organ transplants continues to rise, the ability to fabricate functional tissues and organs through bioprinting offers a promising solution to address the critical shortage of organ donors. This review systematically explores the applications of 3D bioprinting, beginning with its role in tissue engineering, where it is used to fabricate various tissue types such as skin, cartilage, and vascular structures. The discussion extends to organ printing, highlighting the current state of research in creating organ-like constructs and the challenges associated with scaling these technologies for clinical use. Furthermore, we delve into the impact of 3D bioprinting on drug development and testing, examining how bioprinted models can enhance the drug discovery process and facilitate the development of personalized medicine. The challenges and limitations of 3D bioprinting, including technical hurdles and regulatory considerations, are also addressed. By synthesizing the latest findings and advancements in 3D bioprinting, this report aims to provide a comprehensive overview of its applications and implications for the future of biomedicine, ultimately highlighting the transformative potential of this technology in addressing pressing medical challenges.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Applications of 3D Bioprinting
    • 2.1 Tissue Engineering
    • 2.2 Organ Printing
    • 2.3 Drug Development and Testing
    • 2.4 Personalized Medicine
  • 3 Technologies and Materials Used in 3D Bioprinting
    • 3.1 Bioprinting Techniques
    • 3.2 Biomaterials for Bioprinting
  • 4 Challenges and Limitations
    • 4.1 Technical Challenges
    • 4.2 Regulatory and Ethical Considerations
  • 5 Future Directions
    • 5.1 Innovations in Bioprinting Technology
    • 5.2 Potential Impact on Healthcare
  • 6 Conclusion

1 Introduction ​

Three-dimensional (3D) bioprinting has emerged as a transformative technology at the intersection of engineering and life sciences, revolutionizing the field of biomedicine by enabling the precise fabrication of complex biological structures. This innovative approach combines living cells with biocompatible materials to create tissue-like constructs that closely mimic the architecture and functionality of human organs. The rapid advancement of 3D bioprinting technologies has garnered significant attention due to their potential applications in various domains, including tissue engineering, regenerative medicine, drug testing, and personalized medicine. As the global demand for organ transplants continues to rise, the ability to fabricate functional tissues and organs through bioprinting offers a promising solution to address the critical shortage of organ donors [1].

The significance of 3D bioprinting lies not only in its capacity to create organ-like structures but also in its potential to enhance drug development processes. Traditional drug testing methods often rely on two-dimensional (2D) cell cultures or animal models, which may not accurately represent human physiology. In contrast, 3D bioprinted models can provide a more physiologically relevant environment, thereby improving the predictive power of preclinical studies [2]. Furthermore, the integration of smart technologies into bioprinted constructs could facilitate high-throughput screening and enable the development of more effective therapies [3].

Currently, the field of 3D bioprinting is witnessing rapid growth, with a myriad of research efforts focused on optimizing bioprinting techniques and materials. Recent advancements have led to the development of diverse bioprinting methods, such as inkjet, extrusion, and laser-assisted bioprinting, each offering unique advantages for specific applications [4]. Additionally, the exploration of novel biomaterials, including hydrogels and bioinks, has expanded the capabilities of bioprinting, allowing for the creation of tissues with enhanced mechanical properties and biological functionality [5].

In this review, we will systematically explore the applications of 3D bioprinting, beginning with its role in tissue engineering, where it is used to fabricate various tissue types, including skin, cartilage, and vascular structures [6]. We will also discuss organ printing, highlighting the current state of research in creating organ-like constructs and the challenges associated with scaling these technologies for clinical use [7]. Furthermore, we will delve into the impact of 3D bioprinting on drug development and testing, examining how bioprinted models can enhance the drug discovery process and facilitate the development of personalized medicine [8].

The challenges and limitations of 3D bioprinting will also be addressed, including technical hurdles related to achieving complex tissue architectures and the regulatory and ethical considerations that accompany the use of bioprinted tissues in clinical settings [9]. Finally, we will discuss future directions for research and development in this rapidly evolving field, emphasizing the potential innovations that could further enhance the capabilities of 3D bioprinting and its applications in healthcare [6].

By synthesizing the latest findings and advancements in 3D bioprinting, this report aims to provide a comprehensive overview of its applications and implications for the future of biomedicine, ultimately highlighting the transformative potential of this technology in addressing pressing medical challenges.

2 Applications of 3D Bioprinting ​

2.1 Tissue Engineering ​

Three-dimensional (3D) bioprinting has emerged as a transformative technology in the field of tissue engineering, enabling the fabrication of complex biological structures with high precision. The applications of 3D bioprinting span various tissues and organs, showcasing its versatility and potential in regenerative medicine.

One of the primary applications of 3D bioprinting is in the creation of tissue analogs. This technology allows for the precise deposition of cell-laden biomaterials, facilitating the construction of functional tissues such as skin, heart valves, blood vessels, bone, and cardiac tissue. The ability to fabricate these tissues with biomimetic properties surpasses traditional methods that rely on seeding cells into scaffolds, which often lack the required spatial and structural precision (Zhang & Wang, 2019) [10].

In the realm of bone tissue engineering, 3D bioprinting has shown significant promise. Researchers have been able to engineer bone tissues that mimic natural bone architecture, addressing challenges related to mechanical properties and integration with host tissues. The technique allows for the customization of scaffolds to match the specific requirements of different bone defects, enhancing the prospects for successful integration and functionality (Matai et al., 2020) [11].

Furthermore, 3D bioprinting is making strides in dental tissue engineering, where it has been applied to create scaffolds for dental pulp, periodontal ligaments, and alveolar bones. The complexity and heterogeneity of these tissues pose unique challenges, but advancements in bioprinting techniques are enabling the development of tailored constructs that support the regeneration of dental tissues (Ostrovidov et al., 2023) [12].

In addition to hard tissues, 3D bioprinting is also being explored for soft tissue applications. For instance, the regeneration of cardiac tissues is a significant area of focus, where bioprinting techniques are employed to create myocardial patches that can restore heart function following injury (Sung et al., 2021) [13]. Similarly, advancements in bioprinting are being utilized to develop vascular grafts, which are critical for cardiovascular applications, as they can support vascularization and integration with surrounding tissues (Jamee et al., 2021) [14].

The technology's adaptability extends to various other fields, including urology, where 3D bioprinting is being investigated for the development of personalized urological tissue constructs, addressing specific patient needs (Lee, 2024) [15]. Additionally, bioprinting is paving the way for innovative approaches in cancer research by creating tumor microenvironments that better mimic in vivo conditions, allowing for more effective drug testing and therapy development (Belgordere et al., 2018) [16].

Despite its promising applications, challenges remain in achieving high-resolution structures and ensuring the viability and functionality of printed tissues. Ongoing research is focused on enhancing the mechanical properties of bioprinted constructs and improving cell behavior within these engineered tissues (Tripathi et al., 2023) [9].

In conclusion, 3D bioprinting holds immense potential in tissue engineering, offering innovative solutions for the regeneration of a wide variety of tissues and organs. Its applications range from bone and dental tissue engineering to cardiac and vascular applications, demonstrating its versatility and capability to address significant challenges in regenerative medicine. As research continues to advance, the integration of 3D bioprinting into clinical practice may revolutionize the treatment landscape for various medical conditions.

2.2 Organ Printing ​

Three-dimensional (3D) bioprinting technology has emerged as a transformative approach in the field of regenerative medicine, with significant applications in organ printing. This technology allows for the precise fabrication of complex, functional tissues and organs by layering biomaterials, cells, and bioactive components in a controlled manner. The following outlines the key applications of 3D bioprinting in organ printing:

  1. Organ Manufacturing: One of the primary applications of 3D bioprinting is the manufacturing of fully functional organs. The technology facilitates the creation of complex organ structures that closely mimic the natural architecture of human tissues. Current advancements enable the successful printing of various organs, including but not limited to the heart, kidneys, liver, and lungs. The ability to print living tissues with specific cellular compositions and architectures offers a promising solution to the critical shortage of donor organs, potentially transforming the landscape of organ transplantation (Huang et al. 2024; Song et al. 2021; Cui et al. 2017) [17][18][19].

  2. Tissue Regeneration: 3D bioprinting plays a crucial role in tissue regeneration by providing scaffolds that support the growth and organization of cells into functional tissues. The technology allows for the incorporation of vascular networks within printed tissues, which is essential for nutrient transport and waste removal, thus enhancing tissue viability and functionality. Recent developments have made strides in integrating vascularization into bioprinted constructs, addressing one of the significant challenges in tissue engineering (Chen et al. 2021; Shin et al. 2022) [20][21].

  3. Personalized Medicine: The customization capabilities of 3D bioprinting allow for the creation of patient-specific organ models. By utilizing medical imaging data, bioprinting can produce tailored implants and organ models that match the unique anatomical and physiological characteristics of individual patients. This personalization enhances the efficacy of medical treatments and surgical interventions, paving the way for more effective and targeted therapies (Gao et al. 2025; Jeong et al. 2024) [22][23].

  4. Disease Modeling: 3D bioprinting is instrumental in developing organ-on-a-chip models that mimic the physiological conditions of human organs. These models can be utilized for drug testing, disease modeling, and studying drug responses in a controlled environment. The ability to replicate the microenvironment of specific organs enhances the understanding of disease mechanisms and accelerates the drug discovery process (Juraski et al. 2023; Lee et al. 2016) [3][24].

  5. Educational and Research Applications: Beyond clinical applications, 3D bioprinting is also valuable in educational settings and research. It enables the creation of complex biological models for teaching purposes and experimental investigations, providing insights into tissue engineering, developmental biology, and regenerative medicine (Xu et al. 2022) [25].

In conclusion, the applications of 3D bioprinting in organ printing are diverse and impactful, addressing critical challenges in organ transplantation, enhancing personalized medicine, facilitating drug discovery, and contributing to educational advancements in biomedical research. The ongoing development of this technology promises to revolutionize the field of regenerative medicine and improve patient outcomes significantly.

2.3 Drug Development and Testing ​

Three-dimensional (3D) bioprinting has emerged as a transformative technology in drug development and testing, offering several innovative applications that enhance the efficacy and safety of pharmaceuticals. The technology enables the fabrication of biomimetic organ and disease models that more accurately mimic human physiology compared to traditional two-dimensional (2D) cultures and animal models, thus facilitating improved drug discovery processes (Yang et al. 2024) [2].

One of the primary applications of 3D bioprinting in drug development is in the creation of personalized medicine. This technology allows for the on-demand printing of drugs tailored to individual patient needs, adjusting the shape, structure, and dosage to fit specific physical conditions. For instance, bioprinted porous tablets can help alleviate swallowing difficulties, while transdermal microneedle patches can reduce patient discomfort (Mihaylova et al. 2024) [26].

Moreover, 3D bioprinting plays a crucial role in drug screening and testing. By constructing complex tissue models that replicate the tumor microenvironment or other disease states, researchers can perform high-throughput screening of drug candidates, leading to more reliable efficacy and safety data that closely resemble clinical observations (Budharaju et al. 2025) [27]. The ability to create tissue models with defined geometries and functional characteristics enhances the reproducibility of drug testing, thus minimizing interspecies variability that often plagues traditional animal testing (Hagenbuchner et al. 2021) [28].

Additionally, 3D bioprinted models are being utilized to replace conventional animal models in preclinical studies. These models can be engineered to incorporate various cell types, thereby providing a more accurate representation of human tissue interactions. For example, bioprinted skin, cardiac, hepatic, and renal models are already being explored for their potential applications in pharmaceutical research (Frankowski et al. 2023) [29]. This shift not only supports ethical considerations in research by adhering to the principles of the 3Rs (Replacement, Reduction, and Refinement) but also addresses the limitations of existing testing methodologies (Li et al. 2023) [30].

The integration of smart cell culture systems and biosensors into 3D bioprinted models further enhances their utility in drug development. These advancements can provide real-time data on cellular responses to drug treatments, thereby improving the predictability of clinical outcomes (Juraski et al. 2023) [3]. Furthermore, the potential for creating organ-on-a-chip systems through 3D bioprinting offers a novel platform for drug testing that can simulate the human body's responses more accurately than traditional methods (Ren et al. 2025) [8].

In summary, the applications of 3D bioprinting in drug development and testing are multifaceted, ranging from personalized medicine and improved drug screening to the creation of sophisticated organ models that enhance the predictive power of preclinical studies. This technology not only holds promise for accelerating the drug discovery process but also for addressing ethical concerns associated with animal testing, ultimately leading to more effective and safer therapeutic interventions.

2.4 Personalized Medicine ​

Three-dimensional (3D) bioprinting has emerged as a transformative technology in personalized medicine, offering numerous applications that significantly enhance patient care and treatment outcomes. The applications of 3D bioprinting can be categorized into several key areas, including organ transplantation, drug development, cancer therapy, and personalized medical devices.

One of the primary applications of 3D bioprinting is in the field of organ transplantation. The technology addresses the critical shortage of donor organs by enabling the fabrication of bioengineered tissues and organs. This advancement can potentially eliminate issues related to organ rejection and the disparities in organ availability due to sex differences in transplantation. By providing a means to create patient-specific organs, 3D bioprinting enhances the survival rates of transplant patients and minimizes complications associated with traditional transplantation methods[31].

In drug development, 3D bioprinting facilitates the creation of personalized drug screening platforms and drug delivery systems tailored to individual patient needs. This includes the ability to print medications on demand, customizing their shape, structure, and dosage to suit specific physiological conditions. For instance, bioprinting can produce porous tablets that are easier to swallow or transdermal microneedle patches that reduce pain during administration[26]. Moreover, bioprinted organoids or organ-on-a-chip models allow for more accurate drug testing and disease modeling, thus reducing the reliance on animal testing and accelerating the clinical trial process[32].

In the realm of cancer therapy, 3D bioprinting is revolutionizing the development of personalized cancer models. These models, which closely mimic the architecture and microenvironment of human tumors, enable high-throughput drug screening and help in identifying the most effective treatment regimens for individual patients. By incorporating patient-derived cancer cells and relevant biomaterials, these bioprinted constructs provide a physiologically relevant platform for evaluating drug responses, thereby facilitating more precise and effective cancer therapies[33].

Additionally, 3D bioprinting is being utilized to develop personalized medical devices and implants. This capability allows for the customization of surgical instruments and prosthetics to fit the unique anatomical and biomechanical properties of individual patients. Such personalization not only improves the functionality of these devices but also enhances patient comfort and satisfaction[34].

Challenges remain in the field of 3D bioprinting, particularly in achieving the precise deposition of cells, effective vascularization, and the integration of bioprinted constructs within the human body. However, ongoing research is focused on overcoming these barriers, with the potential for 3D bioprinting to become a standard practice in personalized medicine, offering tailored solutions that improve therapeutic outcomes and patient quality of life[32][35].

In summary, the applications of 3D bioprinting in personalized medicine are diverse and impactful, ranging from organ transplantation and drug development to cancer therapy and the creation of customized medical devices. The continued advancement of this technology holds great promise for the future of healthcare, potentially transforming how treatments are designed and delivered to patients.

3 Technologies and Materials Used in 3D Bioprinting ​

3.1 Bioprinting Techniques ​

Three-dimensional (3D) bioprinting is an innovative technology that integrates engineering, biology, and medicine, enabling the fabrication of complex living tissue constructs. The applications of 3D bioprinting span various fields, particularly in biomedical applications, which can be categorized into several key areas:

  1. Tissue Engineering and Regenerative Medicine: 3D bioprinting is extensively utilized to create tissue analogs that can mimic the structure and function of native tissues. This includes applications in cardiac tissue engineering, where bioprinted constructs can replicate the intricate architecture of heart tissues, facilitating drug discovery and regenerative strategies for cardiovascular diseases (Khanna et al., 2022; Polonchuk & Gentile, 2021). The ability to incorporate vascular networks into these constructs enhances nutrient and oxygen delivery, which is crucial for maintaining cell viability and functionality (Liu et al., 2023).

  2. Cancer Research: 3D bioprinting is increasingly applied in cancer therapy and research, allowing for the creation of tumor models that closely resemble in vivo conditions. These models enable the study of cancer biology, drug responses, and therapeutic efficacy, providing a more accurate platform for high-throughput screening of potential drug candidates (Tripathi et al., 2023; Yang et al., 2024).

  3. Drug Discovery and Development: The technology has revolutionized drug discovery processes by enabling the development of biomimetic organ and disease models. These 3D bioprinted models offer improved mimicry of human physiology compared to traditional two-dimensional cultures and animal models, thereby enhancing the accuracy of preclinical studies (Vijayavenkataraman et al., 2018; Juraski et al., 2023). They facilitate lead identification and the generation of efficacy and safety data that better reflect clinical outcomes.

  4. Wound Healing and Bone Regeneration: 3D bioprinting has shown promise in applications such as wound healing and bone regeneration. Bioprinted constructs can be tailored to provide the necessary support for tissue repair and regeneration, utilizing specific bioinks that promote cell growth and differentiation (Liu et al., 2023).

  5. Organ-on-a-Chip Models: The technology is also being applied to develop organ-on-a-chip systems, which simulate the physiological functions of organs on a microfluidic platform. These systems are instrumental in studying organ-specific responses to drugs and diseases, thereby advancing precision medicine (Ren et al., 2025).

  6. Personalized Medicine: With the capability to create patient-specific tissue models, 3D bioprinting holds significant potential for personalized medicine. This approach allows for tailored therapeutic strategies based on individual patient profiles, improving treatment outcomes (Vijayavenkataraman et al., 2018).

  7. Bioprinting Techniques and Materials: Various bioprinting techniques have been developed, including inkjet printing, extrusion-based printing, and laser-assisted printing, each offering unique advantages in terms of resolution and material compatibility. The choice of bioinks—materials that can support cell viability and function—is critical, with advancements in the development of bioactive materials that can enhance the performance of bioprinted constructs (Panda et al., 2022; Shafiee & Atala, 2016).

In summary, 3D bioprinting represents a transformative approach in biomedical engineering, with applications ranging from tissue engineering and regenerative medicine to drug discovery and personalized therapies. The ongoing advancements in bioprinting technologies and materials continue to expand the potential applications and effectiveness of this innovative field.

3.2 Biomaterials for Bioprinting ​

Three-dimensional (3D) bioprinting has emerged as a transformative technology with a wide array of applications in the biomedical field, particularly in tissue engineering, regenerative medicine, and drug discovery. This technology integrates biological components, such as living cells and biomaterials, to create complex tissue structures that closely mimic the natural tissue environment. The applications of 3D bioprinting can be categorized into several key areas, reflecting its versatility and potential for innovation.

One of the primary applications of 3D bioprinting is in tissue engineering, where it is utilized to fabricate living tissues and organ constructs. This includes the development of various types of tissues such as skin, cartilage, and vascular tissues, which are essential for repairing or replacing damaged tissues in the body. Recent advancements have enabled the creation of complex tissue structures that incorporate multiple cell types, enhancing their functionality and integration with host tissues (Panda et al. 2022; Tripathi et al. 2023).

Additionally, 3D bioprinting plays a crucial role in the development of organoids and organ-on-a-chip models, which are used for disease modeling and drug testing. These models provide a more accurate representation of human physiology compared to traditional two-dimensional cell cultures, allowing for better understanding of disease mechanisms and more effective drug screening (Ren et al. 2025; Yang et al. 2024). The ability to replicate human organ functions in vitro significantly improves the drug discovery process by enabling high-throughput screening and preclinical studies that yield data more reflective of clinical outcomes (Vijayavenkataraman et al. 2018).

Moreover, 3D bioprinting is being explored for its potential in regenerative medicine, particularly in the fabrication of bioactive scaffolds that can support tissue regeneration. These scaffolds are designed using biocompatible materials that promote cell adhesion, proliferation, and differentiation, thus facilitating the healing of damaged tissues (Liu et al. 2023; Halper 2025). The incorporation of smart biomaterials that respond to environmental stimuli is also an emerging trend, which adds a dynamic element to tissue engineering by allowing for the creation of adaptive tissues (Halper 2025).

In the context of biopharmaceuticals, 3D bioprinting is increasingly recognized for its capability to create tissue models that can be used to study drug interactions and responses. These models can simulate the tumor microenvironment for cancer research, enabling the evaluation of therapeutic efficacy and safety in a controlled setting (Ozbolat et al. 2016; Yang et al. 2024). The customization of bioprinted tissues for specific drug testing applications is paving the way for personalized medicine approaches.

Furthermore, advancements in bioprinting technologies have led to the development of various bioinks—materials that contain living cells and are suitable for printing. These bioinks can be derived from natural or synthetic sources and are tailored to provide the necessary mechanical and biological properties for specific applications (Krujatz et al. 2022; Wangpraseurt et al. 2022). The choice of biomaterials is critical, as it influences the biocompatibility, degradation rates, and overall functionality of the printed constructs.

In summary, the applications of 3D bioprinting span across tissue engineering, drug discovery, regenerative medicine, and the development of organ models. The ongoing research and advancements in biomaterials and printing technologies continue to enhance the capabilities of 3D bioprinting, positioning it as a vital tool in modern biomedical applications. The integration of living cells with biocompatible materials not only facilitates the creation of complex tissue structures but also opens new avenues for innovative therapeutic strategies and personalized healthcare solutions.

4 Challenges and Limitations ​

4.1 Technical Challenges ​

Three-dimensional (3D) bioprinting is a transformative technology in the field of tissue engineering and regenerative medicine, enabling the fabrication of living cellular constructs with complex architectures for various biomedical applications. The primary applications of 3D bioprinting include tissue engineering, organ transplantation, disease modeling, drug screening, and regenerative medicine. Specifically, bioprinting is being explored for the development of functional tissues and organs, including skin, heart valves, blood vessels, bones, and hollow organs, addressing critical challenges such as organ donor shortages and the need for personalized medical solutions [6][17][36].

Despite its promising applications, 3D bioprinting faces significant challenges and limitations that hinder its clinical translation. One of the most pressing challenges is the technical feasibility of creating scalable, vascularized, and functional constructs that can be implanted in humans. Current limitations include difficulties in achieving optimal bioink properties, ensuring precise cell distribution, and maintaining the structural integrity of printed constructs during and after the printing process [6][37][38].

Technical challenges in 3D bioprinting encompass several aspects:

  1. Bioink Composition and Properties: The choice of bioinks is crucial, as they must provide a suitable microenvironment for cell growth, differentiation, and maturation. Existing bioinks often lack the necessary mechanical and biological properties to support complex tissue structures [39][40].

  2. Vascularization: Creating vascularized tissues remains a significant hurdle. Vascular networks are essential for nutrient and oxygen supply in larger constructs, yet current bioprinting techniques struggle to incorporate functional vascular structures [6][36].

  3. Geometric Complexity: The ability to print complex geometries with high fidelity is limited. Achieving the intricate architectures of natural tissues requires advanced printing techniques that are not yet fully developed [41][42].

  4. Cell Viability and Functionality: Maintaining cell viability during the printing process and ensuring that cells function correctly post-implantation is a critical challenge. The mechanical forces involved in bioprinting can adversely affect cell health and functionality [40][43].

  5. Regulatory and Ethical Considerations: The absence of established guidelines and regulatory frameworks for the clinical application of bioprinted tissues raises ethical concerns. These include the need for rigorous testing protocols to evaluate the safety and efficacy of bioprinted constructs before they can be used in clinical settings [38][40].

In summary, while 3D bioprinting holds immense potential for advancing tissue engineering and organ transplantation, significant technical challenges must be addressed to realize its full capabilities in clinical applications. Continuous research and innovation in bioink development, printing technologies, and regulatory frameworks are essential for overcoming these barriers and improving patient outcomes in regenerative medicine.

4.2 Regulatory and Ethical Considerations ​

Three-dimensional (3D) bioprinting is an innovative technology that has emerged as a transformative approach in the fields of tissue engineering, regenerative medicine, and personalized healthcare. The applications of 3D bioprinting are extensive and encompass various domains, including drug testing and development, disease modeling, regenerative medicine, and organ transplantation. By utilizing computer-aided design and manufacturing processes, 3D bioprinting enables the precise deposition of living cells, biomaterials, and biochemicals to create functional human tissues and organs. This capability holds promise for addressing the increasing demand for organs and tissues, thus revolutionizing personalized medicine[44].

Despite its potential, the field of 3D bioprinting faces significant challenges and limitations that impede its clinical translation. One major obstacle is the current limitations in developing functionally mature, clinically relevant tissue equivalents. Issues such as sub-optimal bioink properties, insufficient biomimicry of bioprintable architectures, and the lack of adequate stem/progenitor cells for large-scale cell expansion pose substantial hurdles. Additionally, there is a critical need for well-regulated international standards and guidelines to address the uncertainties surrounding the reliable and scalable production processes of bioprinted constructs[38]. The technical barriers in fabricating vascularized and implantable constructs that meet biomechanical requirements further complicate the path toward successful clinical applications[36].

Moreover, ethical and regulatory considerations are paramount in the advancement of 3D bioprinting technologies. As this technology progresses towards clinical applications, ethical concerns arise regarding the implications of bioprinting human tissues and organs. Issues such as the potential for experimental testing on humans, the lack of international regulatory directives, and the risks associated with significant harm must be thoroughly examined. Ethical questions related to the irreversibility of bioprinted treatments, loss of treatment opportunities, and replicability are critical to the discourse surrounding 3D bioprinting[40].

Regulatory frameworks must evolve to accommodate the unique challenges posed by bioprinting technologies. Current regulations often do not address the specificities of bioprinted products, necessitating updated guidelines to ensure patient safety and product efficacy. Collaboration among scientists, clinicians, and regulatory bodies is essential to navigate these complexities and to establish robust regulatory pathways that can facilitate the successful clinical application of 3D bioprinted tissues and organs[45].

In summary, while 3D bioprinting presents exciting applications with the potential to revolutionize healthcare, it is accompanied by considerable challenges and ethical concerns that must be addressed to ensure responsible development and implementation in clinical settings.

5 Future Directions ​

5.1 Innovations in Bioprinting Technology ​

Three-dimensional (3D) bioprinting technology has emerged as a transformative approach in various fields, particularly in biomedical applications. This innovative technology allows for the fabrication of complex tissue structures, which can closely mimic natural biological systems, thus holding great promise for numerous applications.

One of the most significant applications of 3D bioprinting is in the field of tissue engineering and regenerative medicine. This technology enables the creation of biomimetic, multiscale, multi-cellular tissues that can replace damaged or injured tissues and organs. The capability to print living tissues with specific cellular arrangements allows for the development of functional tissue equivalents that can be used in transplantation and therapeutic applications. Researchers have been able to fabricate various tissue types, including skin, cartilage, and vascular tissues, which have implications for treating a wide range of conditions from burns to degenerative diseases [1].

In addition to tissue engineering, 3D bioprinting is increasingly utilized in drug discovery and development. Bioprinted models can better replicate human physiology compared to traditional two-dimensional cultures and animal models, providing a more accurate platform for studying disease mechanisms and testing drug efficacy. These models facilitate high-throughput screening systems that can significantly enhance the drug development process by providing reliable data that correlates closely with clinical outcomes [2].

Furthermore, the application of 3D bioprinting extends to creating organoids and organ-on-a-chip systems, which are vital for understanding complex biological interactions and drug responses in a controlled environment. These systems can simulate organ functions and disease states, allowing for more precise studies of pathophysiology and therapeutic responses [8].

Innovations in bioprinting technology are continuously evolving. Recent advancements include the integration of smart biomaterials that can respond to environmental stimuli, potentially leading to the development of dynamic tissues that can change shape or function in response to specific conditions [46]. Additionally, the exploration of bacterial bioprinting is opening new avenues for creating bioactive materials that can be utilized in both biomedicine and bioremediation, demonstrating the versatility of 3D bioprinting technologies [5].

As the field progresses, future directions in 3D bioprinting may focus on overcoming existing challenges such as vascularization of large-scale constructs, enhancing biocompatibility, and improving structural stability. These advancements are crucial for the successful application of bioprinted tissues in clinical settings [47]. The potential for 3D bioprinting to contribute to personalized medicine is also significant, as it allows for the customization of tissues based on individual patient needs [9].

In summary, the applications of 3D bioprinting are vast and continually expanding, with significant implications for tissue engineering, drug discovery, and personalized medicine. The ongoing innovations in bioprinting technology promise to further enhance its capabilities and applications in the biomedical field, paving the way for groundbreaking advancements in healthcare.

5.2 Potential Impact on Healthcare ​

Three-dimensional (3D) bioprinting has emerged as a transformative technology in the biomedical field, with a wide array of applications that promise to revolutionize healthcare. The technology combines the principles of traditional 3D printing with biological materials, allowing for the creation of complex tissue constructs and even entire organs. The potential applications of 3D bioprinting span several critical areas, including tissue engineering, regenerative medicine, drug delivery, and personalized medicine.

In the realm of tissue engineering, 3D bioprinting enables the fabrication of living tissues that can mimic the architecture and functionality of natural tissues. This is particularly important for applications such as bone regeneration, where bioprinted scaffolds can support the growth of new bone tissue. The ability to create heterogeneous tissue constructs with specific cell types and growth factors allows for tailored approaches to repairing or replacing damaged tissues[9].

Regenerative medicine is another significant area where 3D bioprinting is making strides. The technology holds the promise of addressing the critical shortage of organ donors by enabling the fabrication of fully functional organs. While organ bioprinting remains a challenging goal, advancements have been made in creating vascularized tissues that can support life[1]. This capability is crucial for the development of transplantable organs, as it enhances the viability of bioprinted constructs and supports the integration of these tissues into the host's body[14].

Moreover, 3D bioprinting is poised to impact drug delivery systems significantly. By utilizing bioinks that can encapsulate therapeutic agents, 3D bioprinting facilitates the creation of drug delivery systems with controlled release profiles. This approach not only improves the bioavailability of drugs but also allows for localized administration, minimizing systemic side effects[35]. Such innovations could enhance the efficacy of treatments for various diseases, including cancer and chronic conditions[48].

Personalized medicine is another promising application of 3D bioprinting. The technology allows for the customization of medical devices and implants to match the unique anatomical and pathological characteristics of individual patients. This personalization can lead to better patient outcomes and reduced complications, as treatments can be tailored to the specific needs of each individual[34].

The future directions of 3D bioprinting in healthcare are expansive. Ongoing research aims to improve the scalability of bioprinting technologies, enhance the mechanical properties of bioinks, and address the challenges of vascularization and tissue integration[3]. Furthermore, the integration of smart biomaterials and 4D bioprinting, which incorporates dynamic changes in response to stimuli, is expected to further advance the capabilities of bioprinting in creating functional tissues and organs[46].

In conclusion, the applications of 3D bioprinting in healthcare are diverse and hold immense potential for improving patient care. As the technology continues to evolve, it is anticipated to play a pivotal role in addressing some of the most pressing challenges in medicine, including organ shortages, personalized treatments, and effective drug delivery systems. The successful implementation of 3D bioprinting could significantly enhance the landscape of regenerative medicine and transform the way we approach treatment and care in the future.

6 Conclusion ​

The applications of 3D bioprinting in biomedicine have shown remarkable potential in revolutionizing tissue engineering, organ transplantation, drug development, and personalized medicine. This technology allows for the precise fabrication of complex biological structures that can closely mimic human tissues and organs, addressing critical challenges such as organ donor shortages and the limitations of traditional drug testing methods. Key findings highlight the successful creation of various tissue types, including skin, bone, and vascular structures, as well as the development of organ-on-a-chip models that enhance drug discovery processes. Despite these advancements, significant challenges remain, including the need for improved vascularization, regulatory frameworks, and ethical considerations surrounding the use of bioprinted tissues in clinical settings. Future research directions should focus on overcoming these technical hurdles, exploring innovative biomaterials, and enhancing the scalability of bioprinting technologies. As the field progresses, 3D bioprinting holds the promise to significantly impact healthcare, leading to more effective treatments and improved patient outcomes.

References ​

  • [1] Sanjairaj Vijayavenkataraman;Wei-Cheng Yan;Wen Feng Lu;Chi-Hwa Wang;Jerry Ying Hsi Fuh. 3D bioprinting of tissues and organs for regenerative medicine.. Advanced drug delivery reviews(IF=17.6). 2018. PMID:29990578. DOI: 10.1016/j.addr.2018.07.004.
  • [2] Kaixing Yang;Lingxin Wang;Sanjairaj Vijayavenkataraman;Yunong Yuan;Edwin C K Tan;Lifeng Kang. Recent applications of three-dimensional bioprinting in drug discovery and development.. Advanced drug delivery reviews(IF=17.6). 2024. PMID:39306280. DOI: 10.1016/j.addr.2024.115456.
  • [3] Amanda C Juraski;Sonali Sharma;Sydney Sparanese;Victor A da Silva;Julie Wong;Zachary Laksman;Ryan Flannigan;Leili Rohani;Stephanie M Willerth. 3D bioprinting for organ and organoid models and disease modeling.. Expert opinion on drug discovery(IF=4.9). 2023. PMID:37431937. DOI: 10.1080/17460441.2023.2234280.
  • [4] Ashkan Shafiee;Anthony Atala. Printing Technologies for Medical Applications.. Trends in molecular medicine(IF=13.8). 2016. PMID:26856235. DOI: 10.1016/j.molmed.2016.01.003.
  • [5] Yifei Liu;Xiudong Xia;Zhen Liu;Mingsheng Dong. The Next Frontier of 3D Bioprinting: Bioactive Materials Functionalized by Bacteria.. Small (Weinheim an der Bergstrasse, Germany)(IF=12.1). 2023. PMID:36549677. DOI: 10.1002/smll.202205949.
  • [6] Suihong Liu;Lijia Cheng;Yakui Liu;Haiguang Zhang;Yongteng Song;Jeong-Hui Park;Khandmaa Dashnyam;Jung-Hwan Lee;Fouad Al-Hakim Khalak;Oliver Riester;Zheng Shi;Serge Ostrovidov;Hirokazu Kaji;Hans-Peter Deigner;José Luis Pedraz;Jonathan C Knowles;Qingxi Hu;Hae-Won Kim;Murugan Ramalingam. 3D Bioprinting tissue analogs: Current development and translational implications.. Journal of tissue engineering(IF=7.0). 2023. PMID:37464999. DOI: 10.1177/20417314231187113.
  • [7] Felix Krujatz;Sophie Dani;Johannes Windisch;Julia Emmermacher;Franziska Hahn;Maria Mosshammer;Swathi Murthy;Juliane Steingröwer;Thomas Walther;Michael Kühl;Michael Gelinsky;Anja Lode. Think outside the box: 3D bioprinting concepts for biotechnological applications - recent developments and future perspectives.. Biotechnology advances(IF=12.5). 2022. PMID:35257786. DOI: 10.1016/j.biotechadv.2022.107930.
  • [8] Yuqing Ren;Congying Yuan;Qimeng Liang;Yuhao Ba;Hui Xu;Siyuan Weng;Yuyuan Zhang;Anning Zuo;Shutong Liu;Peng Luo;Quan Chen;Zhaokai Zhou;Chuhan Zhang;Yukang Chen;Zaoqu Liu;Xinwei Han. 3D Bioprinting for Engineering Organoids and Organ-on-a-Chip: Developments and Applications.. Medicinal research reviews(IF=11.6). 2025. PMID:40452179. DOI: 10.1002/med.22121.
  • [9] Swikriti Tripathi;Subham Shekhar Mandal;Sudepta Bauri;Pralay Maiti. 3D bioprinting and its innovative approach for biomedical applications.. MedComm(IF=10.7). 2023. PMID:36582305. DOI: 10.1002/mco2.194.
  • [10] Shiqing Zhang;Haibin Wang. Current Progress in 3D Bioprinting of Tissue Analogs.. SLAS technology(IF=3.7). 2019. PMID:30257593. DOI: 10.1177/2472630318799971.
  • [11] Ishita Matai;Gurvinder Kaur;Amir Seyedsalehi;Aneesah McClinton;Cato T Laurencin. Progress in 3D bioprinting technology for tissue/organ regenerative engineering.. Biomaterials(IF=12.9). 2020. PMID:31648135. DOI: 10.1016/j.biomaterials.2019.119536.
  • [12] Serge Ostrovidov;Murugan Ramalingam;Hojae Bae;Gorka Orive;Toshinori Fujie;Xuetao Shi;Hirokazu Kaji. Bioprinting and biomaterials for dental alveolar tissue regeneration.. Frontiers in bioengineering and biotechnology(IF=4.8). 2023. PMID:37122863. DOI: 10.3389/fbioe.2023.991821.
  • [13] Kevin Sung;Nisha R Patel;Nureddin Ashammakhi;Kim-Lien Nguyen. 3-Dimensional Bioprinting of Cardiovascular Tissues: Emerging Technology.. JACC. Basic to translational science(IF=7.2). 2021. PMID:34095635. DOI: 10.1016/j.jacbts.2020.12.006.
  • [14] Radia Jamee;Yusha Araf;Iftekhar Bin Naser;Salman Khan Promon. The promising rise of bioprinting in revolutionalizing medical science: Advances and possibilities.. Regenerative therapy(IF=3.5). 2021. PMID:34189195. DOI: 10.1016/j.reth.2021.05.006.
  • [15] Sang Jin Lee. Personalized Reconstruction with Three-dimensional Printed Urological Tissue Constructs.. European urology focus(IF=5.6). 2024. PMID:38326119. DOI: 10.1016/j.euf.2024.01.006.
  • [16] Jorge A Belgodere;Connor T King;Jacob B Bursavich;Matthew E Burow;Elizabeth C Martin;Jangwook P Jung. Engineering Breast Cancer Microenvironments and 3D Bioprinting.. Frontiers in bioengineering and biotechnology(IF=4.8). 2018. PMID:29881724. DOI: 10.3389/fbioe.2018.00066.
  • [17] Guobin Huang;Yuanyuan Zhao;Dong Chen;Lai Wei;Zhiping Hu;Junbo Li;Xi Zhou;Bo Yang;Zhishui Chen. Applications, advancements, and challenges of 3D bioprinting in organ transplantation.. Biomaterials science(IF=5.7). 2024. PMID:38374788. DOI: 10.1039/d3bm01934a.
  • [18] Dabin Song;Yukun Xu;Siyu Liu;Liang Wen;Xiaohong Wang. Progress of 3D Bioprinting in Organ Manufacturing.. Polymers(IF=4.9). 2021. PMID:34578079. DOI: 10.3390/polym13183178.
  • [19] Haitao Cui;Margaret Nowicki;John P Fisher;Lijie Grace Zhang. 3D Bioprinting for Organ Regeneration.. Advanced healthcare materials(IF=9.6). 2017. PMID:27995751. DOI: 10.1002/adhm.201601118.
  • [20] Earnest P Chen;Zeren Toksoy;Bruce A Davis;John P Geibel. 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications.. Frontiers in bioengineering and biotechnology(IF=4.8). 2021. PMID:34055761. DOI: 10.3389/fbioe.2021.664188.
  • [21] Jaemyung Shin;Yoonjung Lee;Zhangkang Li;Jinguang Hu;Simon S Park;Keekyoung Kim. Optimized 3D Bioprinting Technology Based on Machine Learning: A Review of Recent Trends and Advances.. Micromachines(IF=3.0). 2022. PMID:35334656. DOI: 10.3390/mi13030363.
  • [22] Xinshuai Gao;Jianwei Chen;Xiuxiu Zhang;Tao Xu. 3D Bioprinting for Personalized Medicine: Advances, Challenges, and Future Directions.. ACS biomaterials science & engineering(IF=5.5). 2025. PMID:41051796. DOI: 10.1021/acsbiomaterials.5c00740.
  • [23] Yun Geun Jeong;James J Yoo;Sang Jin Lee;Moon Suk Kim. 3D digital light process bioprinting: Cutting-edge platforms for resolution of organ fabrication.. Materials today. Bio(IF=10.2). 2024. PMID:39430572. DOI: 10.1016/j.mtbio.2024.101284.
  • [24] Hyungseok Lee;Dong-Woo Cho. One-step fabrication of an organ-on-a-chip with spatial heterogeneity using a 3D bioprinting technology.. Lab on a chip(IF=5.4). 2016. PMID:27302471. DOI: 10.1039/c6lc00450d.
  • [25] Yuanyuan Xu;Chengjin Wang;Yang Yang;Hui Liu;Zhuo Xiong;Ting Zhang;Wei Sun. A Multifunctional 3D Bioprinting System for Construction of Complex Tissue Structure Scaffolds: Design and Application.. International journal of bioprinting(IF=6.0). 2022. PMID:36404789. DOI: 10.18063/ijb.v8i4.617.
  • [26] Anna Mihaylova;Dobromira Shopova;Nikoleta Parahuleva;Antoniya Yaneva;Desislava Bakova. (3D) Bioprinting-Next Dimension of the Pharmaceutical Sector.. Pharmaceuticals (Basel, Switzerland)(IF=4.8). 2024. PMID:38931464. DOI: 10.3390/ph17060797.
  • [27] Harshavardhan Budharaju;Rajendra K Singh;Hae-Won Kim. Bioprinting for drug screening: A path toward reducing animal testing or redefining preclinical research?. Bioactive materials(IF=20.3). 2025. PMID:40697711. DOI: 10.1016/j.bioactmat.2025.07.006.
  • [28] Judith Hagenbuchner;Daniel Nothdurfter;Michael J Ausserlechner. 3D bioprinting: novel approaches for engineering complex human tissue equivalents and drug testing.. Essays in biochemistry(IF=5.7). 2021. PMID:34328185. DOI: 10.1042/EBC20200153.
  • [29] Joachim Frankowski;Matylda Kurzątkowska;Marcin Sobczak;Urszula Piotrowska. Utilization of 3D bioprinting technology in creating human tissue and organoid models for preclinical drug research - State-of-the-art.. International journal of pharmaceutics(IF=5.2). 2023. PMID:37579828. DOI: 10.1016/j.ijpharm.2023.123313.
  • [30] Yilin Li;Jiaxing Liu;Shun Xu;Jiajun Wang. 3D Bioprinting: An Important Tool for Tumor Microenvironment Research.. International journal of nanomedicine(IF=6.5). 2023. PMID:38164264. DOI: 10.2147/IJN.S435845.
  • [31] Dobromira Shopova;Antoniya Yaneva;Desislava Bakova;Anna Mihaylova;Petya Kasnakova;Maria Hristozova;Yordan Sbirkov;Victoria Sarafian;Mariya Semerdzhieva. (Bio)printing in Personalized Medicine-Opportunities and Potential Benefits.. Bioengineering (Basel, Switzerland)(IF=3.7). 2023. PMID:36978678. DOI: 10.3390/bioengineering10030287.
  • [32] Ethan Hau Yin Lam;Fengqing Yu;Sabrina Zhu;Zongjie Wang. 3D Bioprinting for Next-Generation Personalized Medicine.. International journal of molecular sciences(IF=4.9). 2023. PMID:37047328. DOI: 10.3390/ijms24076357.
  • [33] Robin Augustine;Sumama Nuthana Kalva;Rashid Ahmad;Alap Ali Zahid;Shajia Hasan;Ajisha Nayeem;Lana McClements;Anwarul Hasan. 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy.. Translational oncology(IF=4.1). 2021. PMID:33493799. DOI: 10.1016/j.tranon.2021.101015.
  • [34] Neerajha Nagarajan;Agnes Dupret-Bories;Erdem Karabulut;Pinar Zorlutuna;Nihal Engin Vrana. Enabling personalized implant and controllable biosystem development through 3D printing.. Biotechnology advances(IF=12.5). 2018. PMID:29428560. DOI: 10.1016/j.biotechadv.2018.02.004.
  • [35] Khonzisizwe Somandi;Yahya E Choonara. Exploring the 3D Bioprinting Landscape in the Delivery of Active Pharmaceutical Compounds for Therapeutic and Regenerative Medicine Applications.. Journal of biomedical materials research. Part B, Applied biomaterials(IF=3.4). 2025. PMID:40999931. DOI: 10.1002/jbm.b.35654.
  • [36] Dino J Ravnic;Ashley N Leberfinger;Srinivas V Koduru;Monika Hospodiuk;Kazim K Moncal;Pallab Datta;Madhuri Dey;Elias Rizk;Ibrahim T Ozbolat. Transplantation of Bioprinted Tissues and Organs: Technical and Clinical Challenges and Future Perspectives.. Annals of surgery(IF=6.4). 2017. PMID:28594678. DOI: 10.1097/SLA.0000000000002141.
  • [37] Tanveer Ahmad Mir;Makoto Nakamura. Three-Dimensional Bioprinting: Toward the Era of Manufacturing Human Organs as Spare Parts for Healthcare and Medicine.. Tissue engineering. Part B, Reviews(IF=4.6). 2017. PMID:28103751. DOI: 10.1089/ten.TEB.2016.0398.
  • [38] Tarun Agarwal;Valentina Onesto;Dishary Banerjee;Shengbo Guo;Alessandro Polini;Caleb Vogt;Abhishek Viswanath;Timothy Esworthy;Haitao Cui;Aaron O'Donnell;Kiran Yellappa Vajanthri;Lorenzo Moroni;Ibrahim T Ozbolat;Angela Panoskaltsis-Mortari;Lijie Grace Zhang;Marco Costantini;Tapas Kumar Maiti. 3D bioprinting in tissue engineering: current state-of-the-art and challenges towards system standardization and clinical translation.. Biofabrication(IF=8.0). 2025. PMID:40513614. DOI: 10.1088/1758-5090/ade47a.
  • [39] Ioannis Angelopoulos;Mark C Allenby;Mayasari Lim;Mauricio Zamorano. Engineering inkjet bioprinting processes toward translational therapies.. Biotechnology and bioengineering(IF=3.6). 2020. PMID:31544957. DOI: 10.1002/bit.27176.
  • [40] Frederic Gilbert;Cathal D O'Connell;Tajanka Mladenovska;Susan Dodds. Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.. Science and engineering ethics(IF=3.0). 2018. PMID:28185142. DOI: 10.1007/s11948-017-9874-6.
  • [41] Sang-Hyug Park;Chi Sung Jung;Byoung-Hyun Min. Advances in three-dimensional bioprinting for hard tissue engineering.. Tissue engineering and regenerative medicine(IF=4.1). 2016. PMID:30603444. DOI: 10.1007/s13770-016-0145-4.
  • [42] Yu Shrike Zhang;Kan Yue;Julio Aleman;Kamyar Mollazadeh Moghaddam;Syeda Mahwish Bakht;Jingzhou Yang;Weitao Jia;Valeria Dell'Erba;Pribpandao Assawes;Su Ryon Shin;Mehmet Remzi Dokmeci;Rahmi Oklu;Ali Khademhosseini. 3D Bioprinting for Tissue and Organ Fabrication.. Annals of biomedical engineering(IF=5.4). 2017. PMID:27126775. DOI: 10.1007/s10439-016-1612-8.
  • [43] Qasem Ramadan;Mohammed Zourob. 3D Bioprinting at the Frontier of Regenerative Medicine, Pharmaceutical, and Food Industries.. Frontiers in medical technology(IF=3.8). 2020. PMID:35047890. DOI: 10.3389/fmedt.2020.607648.
  • [44] Giovanna Ricci;Filippo Gibelli;Ascanio Sirignano. Three-Dimensional Bioprinting of Human Organs and Tissues: Bioethical and Medico-Legal Implications Examined through a Scoping Review.. Bioengineering (Basel, Switzerland)(IF=3.7). 2023. PMID:37760154. DOI: 10.3390/bioengineering10091052.
  • [45] Vidhi Mathur;Prachi Agarwal;Meghana Kasturi;Varadharajan Srinivasan;Raviraja N Seetharam;Kirthanashri S Vasanthan. Innovative bioinks for 3D bioprinting: Exploring technological potential and regulatory challenges.. Journal of tissue engineering(IF=7.0). 2025. PMID:39839985. DOI: 10.1177/20417314241308022.
  • [46] Jaroslava Halper. Narrative Review and Guide: State of the Art and Emerging Opportunities of Bioprinting in Tissue Regeneration and Medical Instrumentation.. Bioengineering (Basel, Switzerland)(IF=3.7). 2025. PMID:39851345. DOI: 10.3390/bioengineering12010071.
  • [47] Zhonghua Sun;Jack Zhao;Emily Leung;Maria Flandes-Iparraguirre;Michael Vernon;Jenna Silberstein;Elena M De-Juan-Pardo;Shirley Jansen. Three-Dimensional Bioprinting in Cardiovascular Disease: Current Status and Future Directions.. Biomolecules(IF=4.8). 2023. PMID:37627245. DOI: 10.3390/biom13081180.
  • [48] Swati Panda;Sugato Hajra;Krystian Mistewicz;Bartłomiej Nowacki;Pichaya In-Na;Anastasiia Krushynska;Yogendra Kumar Mishra;Hoe Joon Kim. A focused review on three-dimensional bioprinting technology for artificial organ fabrication.. Biomaterials science(IF=5.7). 2022. PMID:35876134. DOI: 10.1039/d2bm00797e.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

3D Bioprinting · Tissue Engineering · Regenerative Medicine · Drug Development · Personalized Medicine

© 2025 MaltSci